atorvastatin has been researched along with Nephrolithiasis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Huang, HS; Liu, CJ; Tsai, YS | 1 |
| Deng, Y; Guan, X; Kang, J; Li, D; Liu, Q; Liu, Y; Sun, Y; Tao, Z; Wang, X; Xu, H | 1 |
2 other study(ies) available for atorvastatin and Nephrolithiasis
| Article | Year |
|---|---|
Atorvastatin Decreases Renal Calcium Oxalate Stone Deposits by Enhancing Renal Osteopontin Expression in Hyperoxaluric Stone-Forming Rats Fed a High-Fat Diet.
Topics: Animals; Atorvastatin; Calcium; Calcium Oxalate; Diet, High-Fat; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hydroxyproline; Hyperoxaluria; Kidney Calculi; Nephrolithiasis; Osteopontin; Rats; Rats, Sprague-Dawley | 2022 |
Atorvastatin inhibits renal inflammatory response induced by calcium oxalate crystals via inhibiting the activation of TLR4/NF-κB and NLRP3 inflammasome.
Topics: Animals; Antioxidants; Atorvastatin; Blood Urea Nitrogen; Caspase 1; Creatinine; Gene Expression Regulation; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammasomes; Interleukin-1beta; Interleukin-6; Kidney; L-Lactate Dehydrogenase; Male; Malondialdehyde; Nephrolithiasis; NF-kappa B; NLR Family, Pyrin Domain-Containing 3 Protein; Oxidative Stress; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Signal Transduction; Superoxide Dismutase; Toll-Like Receptor 4 | 2020 |